Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Summary

* The primary objective of the trial is to assess the single-dose relative bioavailability of Chemi Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by subcutaneous (s.c.) injection, under fasting conditions in healthy volunteers. * The secondary objective of the trial is to assess safety and tolerability of Chemi Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by s.c. injection, under fasting conditions in healthy volunteers.

Timeline

Start

2014-08-04

Primary completion

2014-12-05

Completion

2014-12-05

Drugs

Indications

No indication recorded.